To ensure the generalizability of clinical trial results and equitable treatment access, enrollment must reflect the diversity of the patient population.
Monica A. Patel, MD
Advertisement
Monica Patel, MD, is an assistant professor in the Division of Hematology, Medical Oncology, and Palliative Care in the Department of Medicine, as well as faculty director of Diversity and Inclusion in Clinical Research at the University of Wisconsin Carbone Cancer Center
Articles by Monica A. Patel, MD
Monica A. Patel, MD, discusses factors that determine whether a patient with hepatocellular carcinoma is a good candidate to receive a combination of atezolizumab and bevacizumab.
Advertisement
Latest Updated Articles
Dr. Patel on Selecting Patients for Treatment With Atezolizumab/Bevacizumab in HCCPublished: May 11th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5